PT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis Review

Date: May 24, 2016
Pages: 36
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P9D235197CDEN
Leaflet:

Download PDF Leaflet

PT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis Review
PT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

PT Kalbe Farma Tbk (Kalbe) is pharmaceutical company, which provides a wide range of healthcare solutions. The company undertakes the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products and healthcare services. It provides its products and services through four divisions namely, Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistics. Some of the prominent brands of the company include Promag, Waisan, Neo-entrostop, Woods, Komix, Mextril, Mixadin Procold Mixagrip, Prenagen and Extra Joss, among others. It has operational presence with offices located in ASEAN countries, Nigeria, and South Africa. Kalbe is headquartered in Jakarta, Indonesia.

PT Kalbe Farma Tbk Key Recent Developments

Jan 05, 2016: Kalbe Farma and Kimia Farma to Open Raw Materials Plants in Indonesia

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

PT Kalbe Farma Tbk - Key Facts
PT Kalbe Farma Tbk - Key Employees
PT Kalbe Farma Tbk - Major Products and Services
PT Kalbe Farma Tbk - History
PT Kalbe Farma Tbk - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

PT Kalbe Farma Tbk - Business Description
PT Kalbe Farma Tbk - Corporate Strategy
PT Kalbe Farma Tbk - SWOT Analysis
SWOT Analysis - Overview
PT Kalbe Farma Tbk - Strengths
Strength - Robust R&D Activities
Strength - Improved Performance of Nutritionals Division
Strength - Operational Network
PT Kalbe Farma Tbk - Weaknesses
Weakness - Product Recalls
PT Kalbe Farma Tbk - Opportunities
Opportunity - New Product Launches
Opportunity - Rising Healthcare Expenditure
Opportunity - Strategic Expansions
PT Kalbe Farma Tbk - Threats
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Threat - Competitive Pressures
PT Kalbe Farma Tbk - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
PT Kalbe Farma Tbk, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jan 05, 2016: Kalbe Farma and Kimia Farma to Open Raw Materials Plants in Indonesia

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

PT Kalbe Farma Tbk, Key Facts
PT Kalbe Farma Tbk, Key Employees
PT Kalbe Farma Tbk, Major Products and Services
PT Kalbe Farma Tbk, History
PT Kalbe Farma Tbk, Other Locations
PT Kalbe Farma Tbk, Subsidiaries
PT Kalbe Farma Tbk, Joint Venture
PT Kalbe Farma Tbk, Key Competitors
PT Kalbe Farma Tbk, Ratios based on current share price
PT Kalbe Farma Tbk, Annual Ratios
PT Kalbe Farma Tbk, Interim Ratios
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
PT Kalbe Farma Tbk, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

PT Kalbe Farma Tbk, Performance Chart (2011 - 2015)
PT Kalbe Farma Tbk, Ratio Charts
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
PT Kalbe Farma Tbk, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

PT. Pyridam Farma Tbk.
PT Dexa Medica
PT. SOHO Industri Pharmasi
PT. Combiphar
PT Sanbe Farma
PT Darya-Varia Laboratoria Tbk
PT Tempo Scan Pacific Tbk
PT. Millennium Pharmacon International TBK
Skip to top


Ask Your Question

PT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: